Back
Atara Biotherapeutics Stock Price Chart
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
19
ATRA
Atara Biotherapeutics
Last Price:
$6.91
Seasonality Move:
-15.4%
7 Day Trial
ALL ACCESS PASS
$
7
Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATRA is experiencing slight buying pressure.
Atara Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.94 | Buy |
| 20-day SMA: | 7.23 | Sell |
| 50-day SMA: | 9.27 | Sell |
| 200-day SMA: | 9.72 | Sell |
| 8-day EMA: | 7.04 | Sell |
| 20-day EMA: | 7.4 | Sell |
| 50-day EMA: | 8.56 | Sell |
| 200-day EMA: | 12.08 | Sell |
Atara Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.55 | Sell |
| Relative Strength Index (14 RSI): | 43.76 | Sell |
| Chaikin Money Flow: | 9583 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.71 - 8.45) | Sell |
| Bollinger Bands (100): | (7.52 - 12.88) | Sell |
Atara Biotherapeutics Technical Analysis
| Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Atara Biotherapeutics Stock
Is Atara Biotherapeutics Stock a Buy?
-
Atara Biotherapeutics share price is 7.02 while ATRA 8-day simple moving average is 6.94, which is a Buy signal.
-
The stock price of ATRA is 7.02 while Atara Biotherapeutics 20-day SMA is 7.23, which makes it a Sell.
-
Atara Biotherapeutics 50-day simple moving average is 9.27 while ATRA share price is 7.02, making it a Sell technically.
-
ATRA stock price is 7.02 and Atara Biotherapeutics 200-day simple moving average is 9.72, creating a Sell signal.
ATRA Technical Analysis vs Fundamental Analysis
Sell
19
Atara Biotherapeutics (ATRA)
is a Sell
Is Atara Biotherapeutics a Buy or a Sell?
-
Atara Biotherapeutics stock is rated a SellThe current Atara Biotherapeutics [ATRA] share price is $7.02. The Score for ATRA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Atara Biotherapeutics Stock Info
Market Cap:
41.1M
Price in USD:
7.02
Share Volume:
47.9K
Atara Biotherapeutics 52-Week Range
52-Week High:
20.81
52-Week Low:
5.40
Sell
19
Atara Biotherapeutics (ATRA)
is a Sell
Atara Biotherapeutics Share Price Forecast
-
What is the Atara Biotherapeutics stock price today?The Atara Biotherapeutics stock price is 7.02 USD today.
-
Will ATRA stock go up or go down?Atara Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Atara Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atara Biotherapeutics is overvalued.
Is Atara Biotherapeutics Stock a Buy?
-
Atara Biotherapeutics share price is 7.02 while ATRA 8-day exponential moving average is 7.04, which is a Sell signal.
-
The stock price of ATRA is 7.02 while Atara Biotherapeutics 20-day EMA is 7.40, which makes it a Sell.
-
Atara Biotherapeutics 50-day exponential moving average is 8.56 while ATRA share price is 7.02, making it a Sell technically.
-
ATRA stock price is 7.02 and Atara Biotherapeutics 200-day simple moving average is 12.08, creating a Sell signal.
Fundamental Analysis of Atara Biotherapeutics
Is Atara Biotherapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $2.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.60 per share, and an increase next year of $4.98 per share.
Technical Analysis of Atara Biotherapeutics
Should I short Atara Biotherapeutics stock?
-
ATRA Moving Average Covergence Divergence (MACD) indicator is -0.55, suggesting Atara Biotherapeutics is a Sell
-
Atara Biotherapeutics Relative Strength Index (RSI) is 43.76, which suggest Atara Biotherapeutics is oversold
-
The Bollinger Bands (25) for Atara Biotherapeutics is (6.71 - 8.45), which suggest Atara Biotherapeutics is a Sell
-
The Bollinger Bands (100) for Atara Biotherapeutics is (7.52 - 12.88), which suggest Atara Biotherapeutics is a Sell
* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.